About this Research Topic
This Research Topic is led by Letizia Leocani and Leigh Charvet and is part of the Telemedicine in Neurology series:
Volume 1 – In Neuro-Otology, Neuro-Ophthalmology, and Movement Disorders Patient Care and Treatment (Topic Editors: Amir Kheradmand, Susanne Schneider, Mario Manto, Aasef Shaikh)
Volume 2 – In Dementia Patient Care and Treatment (Topic Editors: Silvan Licher, Frank Wolters, Blossom Stephan)
Volume 3 – Telemedicine in Neurology: Volume 3 – In Stroke Patient Care and Treatment (Topic Editors: Thierry Moulin, Bart Demaerschalk, and Thanh Phan)
Telemedicine in neurology has been a subject of debate and, until recently, was largely restricted to certain subspecialties and clinical scenarios. The COVID-19 pandemic, however, has driven clinicians to rapidly adopt virtual medicine for remote diagnosis and treatment of conditions previously managed in person. This sudden expansion of virtual medicine has ignited enthusiasm for broadening the traditional model of in-person patient consultations, and has created an unprecedented opportunity for developing innovative solutions to improve patient care. In this new era, there is a need for further research to validate and standardize novel approaches for neurological evaluation of patients within the current regulatory frameworks.
Teleneurology has a growing and important role in MS. People with MS often face a chronic, variable, and sometimes largely unpredictable disease course that requires ongoing disease management and prompt symptomatic treatment. The routine clinical assessment of people with MS may miss many of the more subtle disease characteristics. It may also lack the adequate granularity for the detection of fluctuations or relapses with reversible symptoms and signs that may have disappeared at the next regularly planned visit. Moreover, patients often have immediate needs for assessment and care due to exacerbation, relapse, or progression.
The goal of this Research Topic is to provide a comprehensive picture of the current status of telemedicine applications in MS, within three general areas. The first general topic area of application is the inclusion of teleneurology visits as part of comprehensive MS clinical care, both for reaching patients during the COVID-19 pandemic and in the context of ongoing management and supportive care. Studies may also address the unique challenges in reaching patients with MS remotely and at home. The second general topic area is the use of teleneurology for remote assessment and monitoring of patients with MS. This can include the use of remote diagnostics and devices for symptom measurement and monitoring. Studies may describe the development of new technologies or the use of existing technologies adapted for use in MS care. The third general topic area is teleneurology for remote delivery of interventions and treatments. This topic may include tele-interventions for physical and cognitive rehabilitation, psychological support, and symptomatic treatment. Studies can address any of these areas, evaluating both technical development and validation as well as clinical application.
We welcome manuscripts, including Reviews and Original Research, addressing any aspect of teleneurology in the context of MS as described above. Studies can address the use of teleneurology in MS clinical care, the development of new technologies or application of existing technologies, or the validation of remote assessments and interventions.
Keywords: tele-health in MS
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.